Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 

Publications

Showing records 1 - 20 (of 89)

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID Author Year Title Publisher
3704516  Marzolini, Catia; Decosterd, Laurent A.; Shen, Fei; Gander, Marc; Leyvraz, Serge; Bauer, Jean; Buclin, Thierry; Biollaz, Jérôme; Lejeune, Ferdy 1998 Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration Cancer chemotherapy and pharmacology
3704514  Gander, M.; Leyvraz, S.; Decosterd, L.; Bonfanti, M.; Marzolini, C.; Shen, F.; Liénard, D.; Perey, L.; Colella, G.; Biollaz, J.; Lejeune, F.; Yarosh, D.; Belanich, M.; D'Incalci, M. 1999 Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours Annals of Oncology
3704511  Marzolini, C.; Telenti, A.; Buclin, T.; Biollaz, J.; Decosterd, L. A. 2000 Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction Journal of Chromatography B
3704507  Marzolini, Catia; Telenti, Amalio; Decosterd, Laurent A.; Greub, Gilbert; Biollaz, Jérôme; Buclin, Thierry 2001 Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients AIDS
3704502  Marzolini, Catia; Buclin, Thierry; Decosterd, Laurent Arthur; Biollaz, Jérôme; Telenti, Amalio 2001 Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability Therapeutic drug monitoring
3704496  Marzolini, Catia; Rudin, Christoph; Decosterd, Laurent A.; Telenti, Amalio; Schreyer, Alain; Biollaz, Jérôme; Buclin, Thierry; Swiss Mother + Child HIV Cohort Study, 2002 Transplacental passage of protease inhibitors at delivery AIDS
3704494  Marzolini, C.; Béguin, A.; Telenti, A.; Schreyer, A.; Buclin, T.; Biollaz, J.; Decosterd, L. A. 2002 Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery Journal of Chromatography B
3704498  Fellay, Jacques; Marzolini, Catia; Meaden, Emma R.; Back, David J.; Buclin, Thierry; Chave, Jean Philippe; Decosterd, Laurent A.; Furrer, Hansjakob; Opravil, Milos; Pantaleo, Giuseppe; Retelska, Dorota; Ruiz, Lidia; Schinkel, Alfred H.; Vernazza, Pietro; Eap, Chin B.; Telenti, Amalio; Swiss HIV Cohort Study, 2002 Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study The Lancet
3704490  Csajka, Chantal; Marzolini, Catia; Fattinger, Karin; Décosterd, Laurent A.; Fellay, Jacques; Telenti, Amalio; Biollaz, Jérôme; Buclin, Thierry 2003 Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection Clinical Pharmacology and Therapeutics
3704480  Colombo, S.; Guignard, N.; Marzolini, C.; Telenti, A.; Biollaz, J.; Decosterd, L. A. 2004 Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction Journal of Chromatography B
3704484  Marzolini, Catia; Tirona, Rommel G.; Kim, Richard B. 2004 Pharmacogenomics of the OATP and OAT families Pharmacogenomics
3704488  Marzolini, Catia; Paus, Erik; Buclin, Thierry; Kim, Richard B. 2004 Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance Clinical Pharmacology and Therapeutics
3704478  Haas, David W.; Ribaudo, Heather J.; Kim, Richard B.; Tierney, Camlin; Wilkinson, Grant R.; Gulick, Roy M.; Clifford, David B.; Hulgan, Todd; Marzolini, Catia; Acosta, Edward P. 2004 Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study AIDS : official journal of the International AIDS Society
3704482  Csajka, Chantal; Marzolini, Catia; Fattinger, Karin; Décosterd, Laurent A.; Telenti, Amalio; Biollaz, Jérôme; Buclin, Thierry 2004 Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus Antimicrobial Agents and Chemotherapy
3704486  Bleiber, Gabriela; May, Margaret; Suarez, Carlos; Martinez, Raquel; Marzolini, Catia; Egger, Matthias; Telenti, Amalio; Swiss HIV Cohort Study, 2004 MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment Journal of Infectious Diseases
3704476  Fellay, Jacques; Marzolini, Catia; Decosterd, Laurent; Golay, Kerry Powell; Baumann, Pierre; Buclin, Thierry; Telenti, Amalio; Eap, Chin B. 2005 Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients European Journal of Clinical Pharmacology
3704472  Colombo, Sara; Béguin, Alexandre; Marzolini, Catia; Telenti, Amalio; Biollaz, Jérôtne; Decosterd, Laurent Arthur 2006 Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction Journal of Chromatography B
3704470  Ribaudo, Heather J.; Haas, David W.; Tierney, Camlin; Kim, Richard B.; Wilkinson, Grant R.; Gulick, Roy M.; Clifford, David B.; Marzolini, Catia; Fletcher, Courtney V.; Tashima, Karen T.; Kuritzkes, Daniel R.; Acosta, Edward P.; Adult AIDS Clinical Trials Group Study, 2006 Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study Clinical Infectious Diseases
3704467  Marzolini, Catia; Tirona, Rommel G.; Gervasini, Guillermo; Poonkuzhali, Balasubramanian; Assem, Mahfoud; Lee, Wooin; Leake, Brenda F.; Schuetz, John D.; Schuetz, Erin G.; Kim, Richard B. 2007 A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression Molecular Endocrinology
3704465  Krishnamurthy, Partha; Schwab, Matthias; Takenaka, Kazumasa; Nachagari, Deepa; Morgan, Jessica; Leslie, Mark; Du, Weinan; Boyd, Kelli; Cheok, Meyling; Nakauchi, Hiromitsu; Marzolini, Catia; Kim, Richard B.; Poonkuzhali, Balasubramanian; Schuetz, Erin; Evans, William; Relling, Mary; Schuetz, John D. 2008 Transporter-mediated protection against thiopurine-induced hematopoietic toxicity Cancer Research
Showing records 1 - 20 (of 89)


MCSS v5.8 PRO. 0.036 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
27/04/2024